Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank28
Year-over-Year Change
Year-over-year book value per share growth
Percentile
P28
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -78.19% |
| Q2 2025 | -28.44% |
| Q1 2025 | -29.39% |
| Q4 2024 | -16.20% |
| Q3 2024 | 344.76% |
| Q2 2024 | -91.81% |
| Q1 2024 | 3232.58% |
| Q4 2023 | -176.68% |
| Q3 2023 | -77.51% |
| Q2 2023 | 1253.34% |
| Q1 2023 | 98.08% |
| Q4 2022 | 81.13% |
| Q3 2022 | -609.42% |
| Q2 2022 | -157.63% |
| Q1 2022 | 112.03% |
| Q4 2021 | -2032.06% |
| Q3 2021 | -104.93% |
| Q2 2021 | 204.14% |
| Q1 2021 | -4866.74% |
| Q4 2020 | -101.99% |
| Q3 2020 | 9715.51% |
| Q2 2020 | -48.89% |
| Q1 2020 | -95.11% |
| Q4 2019 | -6.20% |
| Q3 2019 | -0.61% |
| Q2 2019 | 0.06% |
| Q1 2019 | -0.21% |
| Q4 2018 | 0.48% |
| Q3 2018 | -2.64% |
| Q2 2018 | 2.79% |
| Q1 2018 | -2.22% |
| Q4 2017 | 1000549.19% |
| Q3 2017 | 0.00% |